Aaron D. Berger, MD

Chief Medical Officer and Director of Clinical Research

Disclosure information not submitted.

Presentation(s):

• ERLEADA® (apalutamide)—For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) | Sponsored By: Janssen

  Saturday, April 29, 2023
  9:30 AM – 10:30 AM CST